Dynamics of FSH-induced follicular growth in subfertile women: Relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone

Human Reproduction

Volumn 21, Issue 6, 2006, Pages 1436-1441

  Fleming, R ^a   Deshpande, N ^a   Traynor, I ^a   Yates, R W S ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

AMH; Follicle cohort; FSH; Oocyte yield; PCOS

Indexed keywords

FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; MUELLERIAN INHIBITING FACTOR; RECOMBINANT FOLLITROPIN;

ADULT; AGE DISTRIBUTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; FEMALE; FEMALE SUBFERTILITY; FOLLITROPIN BLOOD LEVEL; HORMONE SENSITIVITY; HUMAN; INFERTILITY THERAPY; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; OOCYTE DONATION; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION;

EID: 33749003091     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei499     Document Type: Article

References (19)

1. Baird DT (1983) Factors regulating the growth of the pre-ovulatory follicle in sheep and humans. J Reprod Fertil 69,343-352.
2. Faddy MJ (2000) Follicular dynamics during ovarian ageing. Mol Cell Endocrinol 163,43-48.
3. Fleming R, Harborne L, MacLaughlin DT, Ling D, Norman J, Sattar N and Seifer DB (2005) Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment. Fertil Steril 83,130-136.
4. Gougeon A (1996) Regulation of ovarian follicular development in primates: Facts and hypotheses. Endocr Rev 17,121-155.
5. Gougeon A (1998) Ovarian follicular growth in humans: Ovarian ageing and population of growing follicles. Maturitas 12 (30),137-142.
6. Hussein MR (2005) Apoptosis in the ovary: Molecular mechanisms. Hum Reprod Update 11,162-177.
7. Jonard S and Dewailly D (2004) The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 10,107-117.
8. Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH and Fauser BC (2004) Anti-mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 89,318-323.
9. Lintsen AM, Pasker-de Jong PC, de Boer EJ, Burger CW, Jansen CA, Braat DD and van Leeuwen FE (2005) Effects of subfertility cause, smoking and body weight on the success rate of IVF. Hum Reprod 20,1867-1875.
10. Maciel GA, Baracat EC, Benda JA, Markham SM, Hensinger K, Chang RJ and Erickson GF (2004) Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. J Clin Endocrinol Metab 89,5321-5327.
11. Macklon NS and Fauser BC (2003) Mild stimulation in in vitro fertilization. Ann N Y Acad Sci 997,105-111.
12. Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM and Serhal P (2005) Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG 112,1384-1390.
13. Nestler JE (1993) Sex hormone binding globulin: A marker for hyperinsulinaemia or insulin resistance? J Clin Endocrinol Metab 76,273-274.
14. Out HJ, Braat DD, Lintsen BM, Gurgan T, Bukulmez O, Gokmen O, Keles G, Caballero P, Gonzalez JM, Fabregues F et al. (2000) Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation. Hum Reprod 15,29-35.
15. Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A and Tapanainen JS (2005) Serum anti-mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 20,1820-1826.
16. van Rooij IAJ, Broekmans FJM, te Velde ER, Fauser BCJM, Bancsi LFJMM, de Jong FH and Themmen APN (2002) Serum anti-Müllerian hormone levels: A novel measure of ovarian reserve. Hum Reprod 17,3065-3071.
17. Seifer DB, MacLaughlin DT, Christian BP, Feng B and Shelden RM (2002) Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 77,468-471.
18. Van Hooff MHV, Alberda AT, Huisman GJ, Zeilmaker GH and Leerentveld RA (1993) Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: A randomised study. Hum Reprod 8,369-373.
19. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Viss JA, Kramer P, Fauser BC and Themmen AP (2004) Anti-mullerian hormone expression pattern in the human ovary: Potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 10,77-83.